Global Cancer Gene Panel and Profiling Market: In-Depth Analysis and Forecasts for 2024-2029
MarkNtel Advisors, a leading market research firm, has showed its latest study titled "Cancer Gene Panel and Profiling Market", offering a detailed industry overview and market perspective. This comprehensive research provides insights into the current state of the market, highlighting recent advancements and emerging trends.
The report combines in-depth quantitative analysis with qualitative analysis; it ranges from macro-overviews of the overall market size, industry chain, and market dynamics to micro details of segment markets. This, as a result, provides a thorough overview of the industry under study as well as a profound understanding of all of its important features.
Analysis and Insights into the Cancer Gene Panel and Profiling Market: 2024-2029
The Global Cancer Gene Panel & Profiling Market is estimated to grow at a CAGR of around 15.5% during the forecast period, i.e., 2024-29. The exponential increase in the incidence of cancer has emerged as a key driver propelling the market growth for cancer gene panels & profiling testing services. For instance, according to the Global Cancer Observatory, in 2022, there were approximately 19.3 million new cases & 10.3 million deaths due to cancer all across the globe. Breast Cancer in females surpassed lung cancer in 2020, thereby becoming the most common type of diagnosed cancer with 11.7% prevalence, followed by lung cancer at 11.4%, colon cancer at 10%, prostate cancer at 7.3%, and stomach cancer at 5.6%.
Request Free Sample of the Report - https://www.marknteladvisors.com/query/request-sample/cancer-gene-panel-profiling-market.html
What are the primary factors driving the growth of the Cancer Gene Panel and Profiling Market?
Growing Prevalence of Hereditary Cancer Cases Globally – The escalating prevalence of hereditary cancer occurrences on a global scale has amplified the demand for genetic panels & profiling testing within the market. This has been mainly because the cancer gene panel and profiling services are highly effective & accurate in the detection of hereditary cancer cases.
Also, genetic testing companies have started offering a comprehensive array of services, including advanced screening & diagnostics in recent years. As a result, there has been an increasing adoption of these testing services by research institutions & clinical laboratories engaged in detecting biomarkers of hereditary cancer cases. This robust adoption trajectory is a direct response to the persistent surge in hereditary cancer cases, as evidenced by historical trends. For instance:
- In 2022, the National Cancer Institute indicated that approximately 10% of all cancer cases witnessed were attributable to hereditary genetic mutations.
As the mutations in hereditary cancer are only pinpointed to specific genes responsible for shielding the body against cancer, it led to genetic testing services coming up as a pivotal method of diagnosis. Notably, clinicians have embraced this technique with significant impact, thereby fostering substantial growth within the Cancer Gene Panel and Profiling Market.
Cancer Gene Panel and Profiling Market Segmentation:
The Cancer Gene Panel and Profiling market is categorized in to different segments. Analyzing growth across these segments enables a comprehensive understanding of key growth areas within the industry. This segmentation provides valuable market insights, empowering stakeholders to make strategic decisions and identify primary market applications effectively.
By Technology
- Next-generation Sequencing (NGS)- Market Size & Forecast 2019-2029, USD Million
- Polymerase Chain Reaction(PCR)- Market Size & Forecast 2019-2029, USD Million
- Microarray- Market Size & Forecast 2019-2029, USD Million
- Mass Spectrometry- Market Size & Forecast 2019-2029, USD Million
- Others (Fluorescence in-situ hybridization, Immunohistochemistry, etc.)- Market Size & Forecast 2019-2029, USD Million
By Application
- Oncology Research- Market Size & Forecast 2019-2029, USD Million
- Personalized Medicine- Market Size & Forecast 2019-2029, USD Million
- Drug Development- Market Size & Forecast 2019-2029, USD Million
- Clinical Diagnostics- Market Size & Forecast 2019-2029, USD Million
By Cancer Type
- Breast Cancer- Market Size & Forecast 2019-2029, USD Million
- Lung Cancer- Market Size & Forecast 2019-2029, USD Million
- Prostrate Cancer- Market Size & Forecast 2019-2029, USD Million
- Colorectal Cancer- Market Size & Forecast 2019-2029, USD Million
- Others (Ovarian Cancer, Leukemia, etc.) - Market Size & Forecast 2019-2029, USD Million
By Cell Type
- Germline - Market Size & Forecast 2019-2029, USD Million
- Somatic - Market Size & Forecast 2019-2029, USD Million
By End-User
- Hospital & Clinics- Market Size & Forecast 2019-2029, USD Million
- Research Institutes- Market Size & Forecast 2019-2029, USD Million
- Diagnostic Laboratories- Market Size & Forecast 2019-2029, USD Million
- Pharmaceutical and Biotechnology- Market Size & Forecast 2019-2029, USD Million
Geographical Analysis into the Cancer Gene Panel and Profiling Market:
The Cancer Gene Panel and Profiling market is categorized based regional:
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
View Full Report [Including Description + TOC] - https://www.marknteladvisors.com/research-library/cancer-gene-panel-profiling-market.html
Competitive Landscape and Cancer Gene Panel and Profiling Market Share Analysis:
The competitive landscape of the Cancer Gene Panel and Profiling Market includes comprehensive details about competitors. These details encompass company overviews, financial performance, revenue generation, market potential, investments in research and development, new market strategies, production facilities, strengths and weaknesses, product launches, ongoing trials, approvals, patents, product range, dominant applications, and technology life cycle.
- 10x Genomics, Inc.
- Caris Lifescience
- Neo genomics
- Flugent Genetics
- Centogene N.V.
- Geneseeq Technology Inc.
- Variantyx
- Genetron Holdings Limited
- Laboratory Corporation of America® Holdings (LabCorp)
- T. G Molecular
- Bio array Diagnostic genetic
- Biorad laboratories Inc.
- Enzo Lifesciences
- Eurofins Scientific
- Nanostring Technologies
- Other
Sent Customized Report Inquiry - https://www.marknteladvisors.com/query/request-customization/cancer-gene-panel-profiling-market.html
Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Questions Addressed in this Study
- What factors are driving the Cancer Gene Panel and Profiling Market growth?
- How is the Cancer Gene Panel and Profiling Market expected to grow over the next five years?
- What are the key insights into the current trends in the Cancer Gene Panel and Profiling Market?
- What is the current size of the Cancer Gene Panel and Profiling Market, and how is it projected to change in the future?
- What is the future outlook for the Cancer Gene Panel and Profiling Market in terms of technological advancements and market expansion?
Why choose MarkNtel?
MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.
Contact Us –
Call: +1 628 895 8081 +91 120 4278433
Email: sales@marknteladvisors.com
Visit to know more: https://www.marknteladvisors.com/
